• Publications
  • Influence
Calcium‐channel Blocker Verapamil Administration in Prolonged and Refractory Status Epilepticus
Summary:  We report on an 11‐year healthy boy who presented refractory status epilepticus (SE), which was unresponsive to conventional antiepileptic drugs used in the algorithm of the treatment ofExpand
  • 132
  • 6
Neuronal migration disorders: clinical, neuroradiologic and genetics aspects
Disorders of neuronal migration are a heterogeneous group of disorders of nervous system development.
  • 98
  • 6
Efficacy and safety of levetiracetam: An add-on trial in children with refractory epilepsy
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and safety of levetiracetam in 110 children with refractory epilepsy, of whom 21 were less than 4 yearsExpand
  • 69
  • 5
Ohtahara syndrome with emphasis on recent genetic discovery
Ohtahara syndrome or Early Infantile Epileptic Encephalopathy (EIEE) with Suppression-Burst, is the most severe and the earliest developing age-related epileptic encephalopathy. Clinically, theExpand
  • 47
  • 5
Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy
We report on the use of the voltage-gated calcium channel blocker (Vg-CCB), verapamil, as an add-on anticonvulsant medication in two girls, 4 and 14 years of age, who were affected by severeExpand
  • 68
  • 4
New trends in neuronal migration disorders.
Neuronal migration disorders are an heterogeneous group of disorders of nervous system development and they are considered to be one of the most significant causes of neurological and developmentalExpand
  • 78
  • 3
Rufinamide in refractory childhood epileptic encephalopathies other than Lennox–Gastaut syndrome
Background:  To report on the first multicenter Italian experience with rufinamide as adjunctive drug in children, adolescents and young adults with refractory childhood‐onset epilepticExpand
  • 37
  • 3
Rufinamide in children and adults with Lennox–Gastaut syndrome: First Italian multicenter experience
This is the first multicenter Italian experience with rufinamide as an adjunctive drug in children, adolescents and adults with Lennox-Gastaut syndrome. The patients were enrolled in a prospective,Expand
  • 39
  • 3
Evaluation and management of nonsyndromic craniosynostosis
Craniosynostosis (craniostenosis) is premature fusion of the sutures of the cranial vault. Several factors can affect the growth of the cranial vault during embryonic life and after birth, leading toExpand
  • 46
  • 3
Metabolic epilepsy: An update
Inborn errors of metabolism comprise a large class of genetic diseases involving disorders of metabolism. Presentation is usually in the neonatal period or infancy but can occur at any time, even inExpand
  • 34
  • 3